Results 161 to 170 of about 12,173,418 (313)

T cells, the Next Big Target in Axial Spondyloarthritis?

Arthritis &Rheumatology, EarlyView.
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley   +1 more source

Re-evaluation of Significance and the Implications of Placebo Effect in Antidepressant Therapy

Frontiers in Psychiatry, 2019
Marko Curkovic, Andro Kosec, Aleksandar Savic, Aleksandar Savic   +3 more
doaj   +1 more source

Placebo Effect on Pain-Related Autonomic Responses in a State of Experimentally-Induced Sensitization. [PDF]

Eur J Pain
Allmendinger F, Utz O, Scheuren PS, Rosner J, Kramer JLK, Hubli M.   +5 more
europepmc   +1 more source

The Placebo Effect in Psychosis: Why It Matters and How to Measure It. [PDF]

Biol Psychiatry Glob Open Sci, 2023
Hird EJ, Diederen K, Leucht S, Jensen KB, McGuire P.   +4 more
europepmc   +1 more source

The placebo effect in our everyday lives

reservedSpesso le nostre scelte di vita quotidiana sono governate da delle forze a noi estranee che inconsapevolmente influiscono sul nostro comportamento.
GENOVESI, MARTA
core  

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo‐Controlled Phase 3 Trials

Arthritis &Rheumatology, EarlyView.
Objective DISSOLVE I and II examined the efficacy and safety of nanoencapsulated sirolimus (NAS) plus pegadricase (NASP) in patients with uncontrolled gout (UG). Methods In these double‐blind, placebo‐controlled Phase 3 trials of NASP, patients were randomized 1:1:1 to infusions of high‐dose (HD) or low‐dose (LD) NAS plus pegadricase (HD NASP, LD NASP,
Herbert S. B. Baraf, Puja P. Khanna, Milan Petronijevic, Mamuka Lortkipanidze, Anand Patel, Kwabena Ayesu, Michael H. Pillinger, Atul Singhal, Joanna Sobierska, Jacquie Christie, Peter Traber, Rehan Azeem, Wesley DeHaan, Hugues Santin‐Janin, Bhavisha Desai, Alan Kivitz   +15 more
wiley   +1 more source

To Ask or Not to Ask: Does Inquiring About Participants' Expectations Influence the Placebo Effect? A Placebo Mechanism Study in Healthy Volunteers. [PDF]

Eur J Pain
Lunde SJ, Emborg C, Kothari SF, Foldager L, Geers AL, Vase L.   +5 more
europepmc   +1 more source

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

Arthritis &Rheumatology, EarlyView.
Objective Nonmelanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with JAK inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Methods This study used data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis linked to the
Zixing Tian, Lianne Kearsley‐Fleet, Sizheng Steven Zhao, James Galloway, Mark Lunt, Kath Watson, Narges Azadbakht, British Society for Rheumatology Biologics Register in Rheumatoid Arthritis Contributors Group, Kimme L. Hyrich   +8 more
wiley   +1 more source

Editorial: Placebo and Nocebo Effects in Psychiatry and Beyond

Frontiers in Psychiatry, 2020
Katja Weimer, Paul Enck, Seetal Dodd, Seetal Dodd, Seetal Dodd, Seetal Dodd, Luana Colloca, Luana Colloca, Luana Colloca   +8 more
doaj   +1 more source

The role of expectations and tailored feedback on the open-label Placebo effect. [PDF]

J Health Psychol
Barnes K, Faasse K.
europepmc   +1 more source